ClinicalTrials.Veeva

Menu

Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia

C

Chongqing Medical University

Status and phase

Unknown
Phase 1

Conditions

Bronchopulmonary Dysplasia

Treatments

Drug: transplantation of hUC-MSCs

Study type

Interventional

Funder types

Other

Identifiers

NCT03873506
yunqiu xia

Details and patient eligibility

About

This is a follow-up study to investigate the long-term safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs), for the treatment of BPD in premature infants. Subjects who participated in and completed the initial stage of the PhaseⅠtrial (NCT03558334 ) will be followed-up until 48 months after the hUC-MSCs transplantation.

Full description

Subjects who completed the initial stage of the PhaseⅠclinical trial will be followed-up at 5 additional visits: 1, 3, 6, 12 and 24 months after the hUC-MSCs transplantation.

Enrollment

30 estimated patients

Sex

All

Ages

1 month to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject who completed the safety and efficacy evaluations in hUC-MSCs PhaseⅠ clinical trial
  2. Subject with a written consent form signed by a legal representative or a parent

Exclusion criteria

  1. Subject whose parent or legal representative does not agree to participate in the study
  2. subject who is considered inappropriate to participate the study by the investigator

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Mesenchymal Stem Cell
Experimental group
Description:
A single intravenous transplantation of Mesenchymal Stem Cell (Dose A - 1 million cells per kg, Dose B - 5 million cells per kg)
Treatment:
Drug: transplantation of hUC-MSCs

Trial contacts and locations

1

Loading...

Central trial contact

Yunqiu Xia; Lin Zou

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems